Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |